1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Nursing Innovation Fund Award to Support ICU Care (2025 Nursing Innovations Fund) is sponsored by AARP and American Association of Critical-Care Nurses (AACN). This competitive grant supports projects that deliver innovative and scalable solutions to strengthen the nursing workforce, foster healthy work environments, and enhance nurse recruitment and retention, with a focus on improving ICU care.
Get alerted about grants like this
Save a search for “AARP and American Association of Critical-Care Nurses (AACN)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
2025 Nursing Innovations Fund | Campaign for Action The Campaign for Action was sunset May 31, 2025. This site is no longer being maintained.
2025 Nursing Innovations Fund AARP and the American Association of Critical-Care Nurses (AACN Critical-Care) have awarded more than $355,000 to 20 projects offering innovative and replicable solutions to strengthen the nursing workforce by creating and sustaining healthy work environments aimed at improving recruitment and retention rates of registered nurses.
Honoring Excellence: A DAISY-Inspired Nursing Recognition and Support Program True Colors: Cultivating Team Dynamics and Retention in Critical Care Nursing American Career College Educational Foundation OptiNURSE (Nursing Unit Resource for Staffing Equity): An AI-Assisted Model for Balanced Nurse-Patient Assignments , Cedars-Sinai Medical Center CCRN ( Critical-care Certified Registered Nurse ) /PCCN (Progressive Care Certified Nurses) Certification Support Program UCHealth MHC ( Memorial Hospital Central) MICU ( Medical Intensive Care Unit) Moments that Matter Project Memorial Health System Foundation Improving Palliative Care Teamwork in the ICU-Interprofessional Education: IMPACT-IPE ( interprofessional education) MedStar Georgetown University Hospital SJMC (St.
Joseph Medical Center) NursePulse: Empowering Care Through Biometric Rings University of Maryland St.
Joseph Medical Center Foundation, Inc. Nurturing Resilience and Transformative Healing: Supporting Trauma Adaptive Recovery (NORTH STAR) You Have to Go Home, and You Can’t Stay Here: ICU Liberation and the Healthy Work Environment AI-Powered Wearables and Peer Support Kaleida Health d/b/a Buffalo General Medical Center A charge nurse is not just a leader – they are the heartbeat of every shift Long Island Jewish Forest Hills Hospital The THRIVE (Teamwork, Healing, Resilience, Integration, Vitality and Engagement) Program: A Pathway to Nursing Success, Retention, and Resilience in the Surgical ICU and Stepdown Maimonides Medical Center Career Continuum: Strategic Pipelining to Strengthen the Nursing Workforce Project HEART (Helping, Educating, and Advancing Resilient Teams) Leading the Charge for Employee Engagement Thomas Jefferson University Hospital, Jefferson Health Addressing the Challenge of Bidirectional Communication in Nursing Units Memorial Hermann Foundation Establishing a Healthy Work Environment for BRH (Blue Ridge Hospice) RNs ICU Recognition TV – I C the AMAZING in U Providence Sacred Medical Center Addressing Moral Distress and Secondary Traumatic Stress Among Hospital nurses who Witness Unexpected Patient Deterioration AACN Critical Care Standards for Establishing and Sustaining Healthy Work Environments AACN Critical Care Healthy Work Environment Assessment Tool (HWEAT) Frequently Asked Questions Video demonstration for setting up HWEAT-Teams survey National Academy of Medicine report, The Future of Nursing 2020-2030: Charting a Path to Achieve Health Equity Nursing Innovations Fund past awardees
Based on current listing details, eligibility includes: Organizations proposing innovative and replicable solutions to strengthen the nursing workforce by creating and sustaining healthy work environments, with past awardees including hospitals and foundations. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Unspecified (over $355,000 awarded to 20 projects in 2025) Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.